BEKE-W
02423
JD HEALTH
06618
TME-SW
01698
4
JD-SW
09618
5
NTES-S
09999
(FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | -34.42%4.05B | ---- | 5.44%6.17B | ---- | -15.07%5.85B | ---- | 898.15%6.89B | --3.45B | -105.83%-863M | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 40.85%-42M | ---- | -12.70%-71M | ---- | 13.70%-63M | ---- | -15.87%-73M | ---- | 56.85%-63M | ---- |
Dividend (income)- adjustment | 0.00%-2M | ---- | ---2M | ---- | ---- | ---- | ---1M | ---- | ---- | ---- |
Attributable subsidiary (profit) loss | 27.78%-26M | ---- | -50.00%-36M | ---- | -200.00%-24M | ---- | -109.09%-8M | ---- | 1,077.78%88M | ---- |
Impairment and provisions: | --384M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | --384M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | 10,311.11%937M | ---- | -97.39%9M | ---- | 175.00%345M | ---- | -106.90%-460M | ---- | 175.75%6.66B | ---- |
-Fair value of investment properties (increase) | 10,311.11%937M | ---- | -97.39%9M | ---- | --345M | ---- | ---- | ---- | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | -106.90%-460M | ---- | 175.75%6.66B | ---- |
Asset sale loss (gain): | -1,800.00%-17M | ---- | -75.00%1M | ---- | 125.00%4M | ---- | -1,500.00%-16M | ---- | -200.00%-1M | ---- |
-Loss (gain) on sale of property, machinery and equipment | -241.67%-17M | ---- | 200.00%12M | ---- | 300.00%4M | ---- | 0.00%1M | ---- | 0.00%1M | ---- |
-Loss (gain) from selling other assets | ---- | ---- | ---11M | ---- | ---- | ---- | -750.00%-17M | ---- | ---2M | ---- |
Depreciation and amortization: | 32.95%117M | ---- | 12.82%88M | ---- | 27.87%78M | ---- | 27.08%61M | ---- | -4.00%48M | ---- |
-Depreciation | 32.95%117M | ---- | 12.82%88M | ---- | 27.87%78M | ---- | 27.08%61M | ---- | -4.00%48M | ---- |
Financial expense | 33.82%926M | ---- | 35.16%692M | ---- | 5.13%512M | ---- | 179.89%487M | ---- | 278.26%174M | ---- |
Special items | -10.84%74M | ---- | -5.68%83M | ---- | 33.33%88M | ---- | 22.22%66M | ---- | -18.18%54M | ---- |
Operating profit before the change of operating capital | -7.73%6.4B | ---- | 2.09%6.93B | ---- | -2.22%6.79B | ---- | 13.82%6.94B | --3.45B | 1.40%6.1B | ---- |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | 268.33%221M | ---- | 123.81%60M | ---- | -3.70%-252M | ---- | 80.05%-243M | ---- | -391.13%-1.22B | ---- |
Accounts payable increase (decrease) | -174.78%-421M | ---- | 1,976.67%563M | ---- | -104.26%-30M | ---- | 221.46%704M | ---- | 28.82%219M | ---- |
Advance payment increase (decrease) | 28.00%32M | ---- | 257.14%25M | ---- | -96.57%7M | ---- | 436.84%204M | ---- | -75.95%38M | ---- |
Special items for working capital changes | 106.18%159M | ---- | -153.00%-2.57B | ---- | 70.16%-1.02B | ---- | -971.70%-3.41B | ---- | -483.13%-318M | ---- |
Cash from business operations | 27.56%6.39B | -3.96%2.69B | -8.93%5.01B | 12.08%2.8B | 30.87%5.5B | -27.56%2.5B | -12.88%4.2B | 21.81%3.45B | -21.97%4.82B | 0.89%2.83B |
Hong Kong profits tax paid | -50.39%-385M | ---- | 3.40%-256M | ---- | 23.41%-265M | ---- | 60.99%-346M | ---- | -778.22%-887M | ---- |
China income tax paid | -0.67%-1.05B | ---- | 5.03%-1.04B | ---- | 2.58%-1.09B | ---- | -115.13%-1.12B | ---- | 31.32%-522M | ---- |
Other taxs | ---- | -18.23%-629M | ---- | 16.48%-532M | ---- | 16.95%-637M | ---- | 4.96%-767M | ---- | -52.55%-807M |
Special items of business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -463.50%-2.61B | ---- | ---463M |
Net cash from operations | 33.51%4.96B | -9.16%2.06B | -10.32%3.71B | 21.85%2.27B | 51.50%4.14B | 2,384.00%1.86B | -19.95%2.73B | -95.20%75M | -35.83%3.41B | -31.42%1.56B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -40.85%42M | ---- | 14.52%71M | ---- | -20.51%62M | ---- | -45.07%78M | ---- | -15.48%142M | ---- |
Dividend received - investment | -24.00%38M | ---- | 100.00%50M | ---- | -34.21%25M | ---- | -19.15%38M | ---- | 9.30%47M | ---- |
Decrease in deposits (increase) | ---24M | 82.90%-33M | ---- | -743.33%-193M | -96.51%41M | 150.00%30M | 64.25%1.18B | --12M | -61.79%716M | ---- |
Sale of fixed assets | --23M | ---- | ---- | ---- | -78.57%15M | ---- | 1,066.67%70M | ---- | -94.87%6M | ---- |
Purchase of fixed assets | -47.83%-170M | -20.40%-1.49B | 95.74%-115M | 10.60%-1.24B | 5.46%-2.7B | 29.88%-1.39B | 8.11%-2.86B | -30.47%-1.98B | 74.66%-3.11B | 84.01%-1.52B |
Recovery of cash from investments | ---- | ---- | --19M | ---- | ---- | ---- | --69M | ---- | ---- | ---- |
Cash on investment | -3.95%-3.08B | ---- | ---2.97B | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items in the investment business | ---- | -24.42%65M | ---- | 115.00%86M | ---- | -72.03%40M | ---- | 286.49%143M | ---- | -69.92%37M |
Net cash from investment operations | -7.93%-3.17B | -8.46%-1.46B | -15.02%-2.94B | -2.28%-1.35B | -79.49%-2.56B | 27.76%-1.32B | 35.15%-1.42B | -23.26%-1.82B | 77.96%-2.2B | 82.99%-1.48B |
Net cash before financing | 130.96%1.78B | -34.89%601M | -51.23%772M | 69.05%923M | 21.02%1.58B | 131.24%546M | 7.48%1.31B | -2,180.95%-1.75B | 126.19%1.22B | 101.31%84M |
Cash flow from financing activities | ||||||||||
New borrowing | 0.74%44.6B | -5.50%22.1B | 27.00%44.27B | 43.28%23.39B | 37.23%34.86B | 29.63%16.32B | 42.22%25.4B | 17.76%12.59B | 49.85%17.86B | 10.57%10.69B |
Refund | 3.39%-37.65B | 8.84%-19.48B | -14.69%-38.97B | -25.22%-21.37B | -87.85%-33.98B | -77.56%-17.07B | -73.82%-18.09B | -27.78%-9.61B | -12.77%-10.41B | -42.59%-7.52B |
Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | 2,800.00%29M | ---- | --1M | ---- |
Interest paid - financing | -7.90%-2.02B | -21.01%-1.01B | -32.44%-1.87B | -17.49%-833M | 0.84%-1.42B | 2.34%-709M | -5.24%-1.43B | -5.99%-726M | 4.10%-1.36B | 3.79%-685M |
Dividends paid - financing | 57.54%-1.71B | 63.28%-991M | -0.10%-4.02B | 0.00%-2.7B | -2.32%-4.02B | -1.73%-2.7B | -3.72%-3.93B | 0.00%-2.65B | -0.96%-3.79B | 5.75%-2.65B |
Other items of the financing business | ---- | -7.14%-15M | ---- | 6.67%-14M | ---- | -215.38%-15M | ---- | 218.18%13M | ---- | ---11M |
Net cash from financing operations | 628.01%3.21B | 139.36%603M | 86.71%-607M | 63.25%-1.53B | -331.17%-4.57B | -977.26%-4.17B | -14.27%1.98B | -116.20%-387M | 192.87%2.31B | -120.72%-179M |
Effect of rate | -45.24%-61M | 82.80%-16M | 83.72%-42M | 29.01%-93M | -453.42%-258M | -645.83%-131M | -47.48%73M | 214.29%24M | 352.73%139M | -136.84%-21M |
Net Cash | 2,923.03%4.99B | 297.70%1.2B | 105.53%165M | 83.19%-609M | -190.90%-2.99B | -69.70%-3.62B | -6.76%3.28B | -2,147.37%-2.14B | 149.41%3.52B | 98.29%-95M |
Begining period cash | 2.39%5.27B | 2.39%5.27B | -38.65%5.15B | -38.65%5.15B | 66.69%8.39B | 66.69%8.39B | 266.64%5.03B | 266.64%5.03B | -83.95%1.37B | -83.95%1.37B |
Cash at the end | 93.47%10.2B | 45.28%6.46B | 2.39%5.27B | -4.12%4.45B | -38.65%5.15B | 58.64%4.64B | 66.69%8.39B | 132.54%2.92B | 266.64%5.03B | -58.92%1.26B |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | 39.49%6.57B | ---- | -0.38%4.71B | ---- | --4.73B | ---- | ---- | ---- | -48.61%3.19B |
Bank deposits | ---- | 57.14%-114M | ---- | -186.02%-266M | ---- | ---93M | ---- | ---- | ---- | 38.60%-1.93B |
Cash and cash equivalent balance | ---- | 45.28%6.46B | ---- | -4.12%4.45B | ---- | --4.64B | ---- | ---- | ---- | -58.92%1.26B |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.